Utang jangka cendhak marang ekuitas haleon.com (HLN)

haleon.com - logo grafis emiten HLN

Haleon plc relies on a global network of plants located near key target markets to ensure stable supplies. The short-term debt to equity trend demonstrates current liquidity, with the parameter reaching 0.10. Strong brands such as Sensodyne and Theraflu, along with a reduction in debt load, are driving the rise in share prices. The regionalization of production minimizes maritime shipping, guaranteeing the constant availability of products in pharmacies.

Rasio utang jangka cendhak marang ekuitas: Haleon PLC (HLN) kanggo 28.04.2023 - 01.11.2026
Sampel barang Haleon

This indicator reflects the dependence of short-term liabilities on equity volume, determining the business's liquidity. The metric measures the company's need for operational borrowings of up to one year relative to its net assets. For Haleon plc (HLN), the reduction of this burden, backed by the strength of the Sensodyne and Theraflu brands, confirms financial stability. The trend in the ratio of current loans to equity demonstrates the effectiveness of the deleveraging strategy and readiness for expansion.

Pesaing wigati

Utang jangka cendhak marang modal KVUE|Utang jangka cendhak marang modal Verona Pharma Inc. (VRNA)|Utang jangka cendhak marang ekuitas Jyong Biotech Ltd MENS|Rasio tanggungan utang jangka cendhak marang modal LGND|AMRX - Utang jangka cendhak marang ekuitas|Perrigo Company PLC (PRGO) - Rasio utang jangka cendhak marang ekuitas|ALVO: Utang jangka cendhak marang modal|Liquidia Inc. (LQDA) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas GLPG|ANIP: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas MannKind (MNKD)|AMPH - Kewajiban jangka cendhak marang modal|Pacira - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal SPRY (ARS Corp)|Theravance Biopharma - Utang jangka cendhak marang modal|Rasio tanggungan utang jangka cendhak marang modal AQST (aquestive.com)|SCPH: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Tectonic Therapeutic (TECX)|Utang jangka cendhak marang ekuitas Tonix Pharmaceuticals Inc.|SXTC: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal EPRX|BHST (bioharvest.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal EXOZ (eXoZymes)|Utang jangka cendhak marang modal Oramed ORMP|ENTX - Utang jangka cendhak marang ekuitas|HYFT: Utang jangka cendhak marang ekuitas|ABVC: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal cumberlandpharma.com (CPIX)|Utang jangka cendhak marang ekuitas Quantum BioPharma|Kewajiban jangka cendhak marang modal FibroGen Inc FGEN|Utang jangka cendhak marang ekuitas Telomir Pharma (TELO)|ranitherapeutics.com - Rasio utang jangka cendhak marang modal|Synergy CHC - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal RLYB|LEXX - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas PULM|ftzy.com.cn (PTHL) - Utang jangka cendhak marang ekuitas|APM (Aptorum Group) - Utang jangka cendhak marang ekuitas|LYRA (Lyra Therapeutics, Inc.) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas impactbiomedinc.com (IBO)|Utang jangka cendhak marang modal TNFA|YCBD (cbdmd.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas PainReform Limited PRFX|Altamira Therapeutics Ltd - Utang jangka cendhak marang ekuitas|LIPO - Utang jangka cendhak marang ekuitas|OPTN (optinose.com) - Rasio utang jangka cendhak marang modal|Pieris Pharmaceuticals, Inc. (PIRS) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas PROC (Procaps Group)|PTPI (Petros) - Utang jangka cendhak marang modal|QLI: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal SLRN|Utang jangka cendhak marang modal tffpharma.com (TFFP)